Tools
Find

Excess Accruals (Sloan) stocks — 159 passing

Sloan accruals ratio beyond ±25%

Sloan accruals ratio beyond ±25%

The Sloan accruals ratio is (net income - operating cash flow - investing cash flow) / total assets. A wide gap between book profit and actual cash flow signals low earnings quality; in practice, within ±10% is normal and beyond ±25% is a warning. Note that a growth company investing heavily can trip this screen on investing outflows alone — check whether a big investment year is behind it. This lens is not a buy signal — it is a screen for stocks to avoid.

A screen for what to avoid — not a buy signal.

This lens has no Track Record summary yet — only scored signals are shown on the Track Record page. The table below is the current pass list.

Stocks passing · 159

StockAccruals ratioNet incomeOperating cash flowInvesting cash flowPrice since latest filing
ALIGOS THERAPEUTICS INC (ALGS)108.6%$-24.2M$-82.5M$-37.8M-75.0% · 13F Jul 1
CURIS INC (CRIS)85.7%$-7.6M$-27.2M$2.5M-93.5% · 13F Jul 1
Infleqtion, Inc. (INFQ)82.0%$-66.9M$-2.3M$-413.0M-41.7% · 13F Jul 1
Veradermics, Inc (MANE)78.9%$-70.0M$-71.6M$-118.9M+27.6% · 13D Aug 24
CYTOMX THERAPEUTICS INC (CTMX)77.8%$-17.4M$-75.6M$-59.7M-46.1% · 13F Jul 1
BICARA THERAPEUTICS INC (BCAX)66.7%$-137.9M$-106.8M$-318.5M-66.8% · 13F Jul 1
NOVAVAX INC (NVAX)64.9%$440.3M$-244.6M$-78.3M-15.9% · 13F Jul 1
MAPLIGHT THERAPEUTICS INC (MPLT)62.6%$-161.2M$-138.1M$-323.2M-45.9% · 13D Aug 19
JADE BIOSCIENCES INC (JBIO)61.3%$-127.4M$-94.7M$-247.0M-29.4% · 13F Jul 1
ASSEMBLY BIOSCIENCES INC (ASMB)57.6%$-6.1M$-41.1M$-113.5M-15.7% · 13F Jul 1
MINERALYS THERAPEUTICS INC (MLYS)57.0%$-154.7M$-142.4M$-389.8M-46.2% · 13F Jul 1
EVOMMUNE INC (EVMN)54.6%$-68.9M$-76.4M$-115.3M-45.2% · 13F Jul 1
COLUMBUS MCKINNON CORP (CMCO)49.6%$-229.5M$-146.2M$-2.5B-2.3% · Form 4 Nov 10
AVALO THERAPEUTICS INC (AVTX)47.2%$-78.3M$-51.5M$-81.7M-58.8% · 13F Jul 1
MACROGENICS INC (MGNX)46.9%$-74.6M$-81.0M$-114.1M-55.6% · 13F Jul 1
DISC MEDICINE INC (IRON)44.9%$-212.2M$-180.4M$-394.3M+2.2% · 13F Jul 1
MONOPAR THERAPEUTICS INC (MNPR)44.0%$-13.7M$-12.2M$-63.5M-25.2% · 13F Jul 1
Beta Bionics, Inc. (BBNX)42.8%$-73.2M$-50.9M$-162.8M-11.9% · 13F Jul 1
Altimmune, Inc. (ALT)40.0%$-88.1M$-67.5M$-132.5M-51.4% · 13F Jul 1
MAZE THERAPEUTICS INC (MAZE)38.2%$-131.1M$-111.9M$-171.0M+10.3% · 13F Jul 1
LSI INDUSTRIES INC (LYTS)38.0%$22.6M$44.1M$-336.6M-26.2% · Form 4 Aug 25
ACADIA PHARMACEUTICALS INC (ACAD)37.3%$391.0M$109.8M$-302.6M-27.3% · 13F Jul 1
MANNKIND CORP (MNKD)36.9%$5.9M$18.3M$-304.8M+0.5% · 13F Jul 1
ALKAMI TECHNOLOGY, INC. (ALKT)36.2%$-47.7M$42.9M$-397.6M-28.1% · 13F Jul 1
NOVA LTD. (NVMI)36.0%$259.2M$245.6M$-837.2M-38.6% · 13F Jul 1
COGENT BIOSCIENCES INC (COGT)35.7%$-328.9M$-264.4M$-399.5M-27.6% · 13F Jul 1
CORVUS PHARMACEUTICALS INC (CRVS)35.6%$-15.3M$-32.8M$-7.8M-4.1% · Form 4 Nov 16
CLEANSPARK INC (CLSK)35.5%$364.5M$-461.0M$-305.7M-54.9% · 13F Jul 1
BELITE BIO, INC (BLTE)33.9%$-77.6M$-37.0M$-305.1M+10.8% · 13F Jul 1
NVIDIA CORP (NVDA)33.6%$120.1B$102.7B$-52.2B-21.3% · 13F Jul 1
LEXEO THERAPEUTICS INC (LXEO)33.1%$-100.0M$-98.6M$-90.3M-35.8% · 13F Jul 1
BIOAGE LABS INC (BIOA)32.6%$-80.6M$-81.6M$-95.2M-79.0% · 13F Jul 1
Nebius Group N.V. (NBIS)31.6%$82.5M$384.8M$-4.2B-25.0% · Form 4 Nov 2
Oklo Inc. (OKLO)30.5%$-105.7M$-82.2M$-489.7M-53.3% · 13D Jul 7
Strategy Inc (MSTR)30.4%$-3.8B$-67.2M$-22.5B+3.3% · 13F Jul 1
COHEN & STEERS, INC. (CNS)30.3%$153.2M$-120.4M$8.4M-11.7% · 13F Jul 1
JOYY Inc. (JOYY)29.8%$2.1B$302.3M$-456.1M+17.8% · 13F Jul 1
APPLIED OPTOELECTRONICS, INC. (AAOI)29.7%$-38.2M$-174.4M$-210.6M-67.5% · 13F Jul 1
ENLIVEN THERAPEUTICS INC (ELVN)29.5%$-103.7M$-70.3M$-173.8M-3.9% · 13F Jul 1
NOVAGOLD RESOURCES INC (NG)28.9%$-94.7M$-14.0M$-177.6M-7.4% · 13D Jul 24
LITHIUM AMERICAS CORP (LAC)28.7%$-86.3M$-61.2M$-765.0M-63.2% · 13F Jul 1
Shift4 Payments, Inc. (FOUR)28.5%$119.0M$634.0M$-3.0B-15.8% · 13F Jul 1
HERC HOLDINGS INC (HRI)28.0%$1.0M$1.1B$-4.9B+0.7% · Form 4 Aug 25
CG ONCOLOGY INC (CGON)27.4%$-161.0M$-132.3M$-245.8M+11.4% · 13F Jul 1
James Hardie Industries plc (JHX)27.2%$104.0M$589.8M$-4.2B+3.5% · 13F Jul 1
CARETRUST REIT INC (CTRE)27.0%$320.5M$394.0M$-1.5B-9.2% · 13F Jul 1
JANUX THERAPEUTICS INC (JANX)26.9%$-113.6M$-82.2M$-301.0M-26.9% · 13F Jul 1
Applied Digital Corp. (APLD)26.8%$-184.3M$89.7M$-2.9B-26.4% · Form 4 Oct 20
Millrose Properties, Inc. (MRP)26.2%$379.9M$3.7B$-5.7B-15.5% · 13F Jul 1
Beam Therapeutics Inc. (BEAM)26.1%$-80.0M$-345.1M$-121.4M-38.3% · 13F Jul 1
KYMERA THERAPEUTICS INC (KYMR)25.4%$-311.4M$-232.9M$-521.1M+6.4% · 13F Jul 1
AST SpaceMobile, Inc. (ASTS)25.3%$-341.9M$-71.5M$-1.5B-55.8% · Form 4 Sep 2
Indivior Pharmaceuticals, Inc. (INDV)25.2%$210.0M$-27.0M$-66.0M+4.0% · Form 4 Aug 28
BROWN & BROWN, INC. (BRO)25.1%$1.1B$1.4B$-7.9B+7.3% · 13F Jul 1
Kodiak Sciences Inc. (KOD)-26.6%$-230.0M$-136.0M$-506.0K-9.6% · Form 4 Nov 9
BridgeBio Pharma, Inc. (BBIO)-28.1%$-732.9M$-445.9M$-24.5M-7.4% · 13D Aug 18
Intellia Therapeutics, Inc. (NTLA)-29.2%$-412.7M$-394.7M$228.0M-43.3% · 13F Jul 1
agilon health, inc. (AGL)-29.4%$-391.3M$-105.8M$88.6M+3.1% · 13F Jul 1
Arlo Technologies, Inc. (ARLO)-29.5%$14.9M$78.7M$27.8M-0.3% · Form 4 Nov 11
MongoDB, Inc. (MDB)-29.7%$-71.2M$505.1M$538.8M-16.9% · 13F Jul 1
Leslie's, Inc. (LESL)-29.7%$-237.0M$8.8M$-25.4M-99.7% · 13F Jul 1
JELD-WEN Holding, Inc. (JELD)-30.1%$-621.2M$-4.9M$16.3M-51.7% · 13F Jul 1
Evolent Health, Inc. (EVH)-30.2%$-534.5M$38.8M$-233.0K-19.5% · 13F Jul 1
EchoStar CORP (ECHO)-30.2%$-14.5B$-99.4M$-1.4B-4.8% · Form 4 Nov 10
FLYEXCLUSIVE INC. (FLYX)-30.3%$-17.6M$6.7M$108.9M-52.9% · 13F Jul 1
Enovis CORP (ENOV)-31.9%$-1.2B$217.3M$-179.4M+0.0% · Form 4 Nov 17
ERASCA INC (ERAS)-32.7%$-124.5M$-95.5M$100.4M-22.5% · 13F Jul 1
ALLOGENE THERAPEUTICS INC (ALLO)-33.0%$-190.9M$-149.2M$95.6M-51.7% · 13D Oct 1
Liberty Global Ltd. (LBTYA)-33.1%$-7.1B$1.2B$-874.9M-9.1% · 13F Jul 1
Liberty Global Ltd. (LBTYK)-33.1%$-7.1B$1.2B$-874.9M-8.1% · 13F Jul 1
AURA BIOSCIENCES INC (AURA)-33.7%$-106.2M$-84.7M$35.6M+6.2% · 13F Jul 1
Cardlytics, Inc. (CDLX)-34.1%$-103.5M$9.3M$-15.3M-71.0% · 13F Jul 1
Andersen Group Inc. (ANDG)-35.0%$-2.3M$184.6M$10.6M+71.0% · 13F Jul 1
Brightstar Lottery PLC (BRSL)-35.5%$147.0M$-99.0M$3.5B-19.7% · 13F Jul 1
EASTMAN KODAK CO (KODK)-35.8%$-128.0M$480.0M$-29.0M+0.0% · Form 4 Nov 17
Capri Holdings Ltd (CPRI)-35.8%$137.0M$77.0M$1.2B+2.9% · 13F Jul 1
CAPRICOR THERAPEUTICS INC (CAPR)-37.3%$-105.0M$-69.8M$97.5M-63.5% · 13F Jul 1
ALUMIS INC (ALMS)-39.2%$-243.3M$-369.5M$287.9M-51.1% · Form 4 Sep 10
Chime Financial, Inc. (CHYM)-39.4%$-1.0B$52.8M$-289.7M+56.9% · 13F Jul 1
AMTECH SYSTEMS INC (ASYS)-40.2%$-30.3M$7.9M$-912.0K-18.0% · Form 4 Sep 17
ACLARIS THERAPEUTICS INC (ACRS)-41.2%$-64.9M$-47.1M$48.4M-36.7% · 13F Jul 1
FRACTYL HEALTH, INC. (GUTS)-41.2%$-141.0M$-90.3M$-557.0K-86.4% · Form 4 Sep 17
Celldex Therapeutics, Inc. (CLDX)-44.1%$-258.8M$-210.9M$209.1M-23.8% · 13F Jul 1
HARLEY-DAVIDSON, INC. (HOG)-49.8%$338.7M$568.9M$3.8B+37.8% · 13F Jul 1
Cullinan Therapeutics, Inc. (CGEM)-50.0%$-219.9M$-175.8M$180.0M-46.3% · 13F Jul 1
Ecovyst Inc. (ECVT)-51.3%$-71.1M$140.3M$435.4M-2.0% · Form 4 Sep 15
Gain Therapeutics, Inc. (GANX)-53.7%$-20.4M$-18.9M$5.0M-40.7% · 13F Jul 1
Artiva Biotherapeutics, Inc. (ARTV)-53.9%$-83.9M$-76.8M$63.4M-61.5% · 13D Jul 24
ARRAY DIGITAL INFRASTRUCTURE, INC. (AD)-55.4%$48.8M$200.8M$2.4B-29.7% · 13D Sep 3
ANTERIS TECHNOLOGIES GLOBAL (AVR)-68.5%$-94.1M$-77.8M$-596.0K-21.4% · Form 4 Oct 9
Damora Therapeutics, Inc. (DMRA)-71.3%$-209.8M$-6.7M$-17.4M+9.2% · Form 4 Sep 29
EDITAS MEDICINE INC (EDIT)-71.6%$-160.1M$-165.2M$138.7M-44.4% · 13F Jul 1
Annexon, Inc. (ANNX)-75.8%$-206.7M$-186.4M$190.1M-13.5% · Form 4 Sep 28
Hinge Health, Inc. (HNGE)-78.7%$-528.3M$171.4M$-113.8M+34.5% · 13F Jul 1
Caribou Biosciences, Inc. (CRBU)-79.5%$-148.1M$-111.0M$102.2M-80.6% · 13F Jul 1
FAETH THERAPEUTICS INC (FTH)-89.1%$-21.1M$-20.5M$19.8M-61.8% · 13F Jul 1
Lumentum Holdings Inc. (LITE)-94.4%$-6.9B$751.4M$-785.5M-30.1% · 13F Jul 1
LARIMAR THERAPEUTICS INC (LRMR)-104.8%$-165.7M$-113.2M$100.3M-6.9% · 13F Jul 1
ACUMEN PHARMACEUTICALS INC (ABOS)-113.8%$-121.3M$-115.5M$133.9M-91.1% · 13F Jul 1
ALX ONCOLOGY HOLDINGS INC (ALXO)-169.6%$-101.7M$-84.1M$82.6M-51.2% · 13F Jul 1
Show all 159 passing stocks
StockAccruals ratioNet incomeOperating cash flowInvesting cash flowPrice since latest filing
SAB BIOTHERAPEUTICS INC (SABS)104.0%$13.3M$-44.8M$-121.7M-21.5% · 13D Aug 11
Q32 BIO INC (QTTB)91.2%$29.8M$-33.5M$7.0M-44.0% · 13D Jul 21
PROTARA THERAPEUTIC INC (TARA)66.1%$-57.4M$-56.4M$-139.5M-42.6% · 13F Jul 1
QXO, Inc. (QXO)63.5%$-279.4M$261.4M$-10.6B-32.8% · 13F Jul 1
Hyperliquid Strategies Inc (PURR)53.5%$305.5M$-19.1M$-777.4M-3.0% · 13F Jul 1
Pony AI Inc. (PONY)50.8%$-134.0M$-165.0M$-889.2M-45.3% · 13F Jul 1
Trevi Therapeutics, Inc. (TRVI)48.3%$-42.8M$-42.1M$-94.1M-23.3% · 13F Jul 1
OVID THERAPEUTICS INC (OVID)46.9%$-17.4M$-38.3M$-49.9M-17.2% · 13F Jul 1
WHITEHAWK THERAPEUTICS INC (WHWK)43.1%$-20.6M$-97.4M$11.9M-28.4% · 13F Jul 1
WESTERN DIGITAL CORP (WDC)42.7%$9.4B$3.9B$-429.0M-52.6% · 13F Jul 1
uniQure N.V. (QURE)36.4%$-199.0M$-178.0M$-321.6M-54.0% · 13F Jul 1
Sionna Therapeutics, Inc. (SION)33.7%$-75.3M$-66.3M$-118.7M-49.0% · 13D Sep 22
Construction Partners, Inc. (ROAD)33.7%$101.8M$291.3M$-1.3B-7.7% · Form 4 Nov 9
SYNOPSYS INC (SNPS)32.6%$1.3B$1.5B$-15.9B-4.2% · 13F Jul 1
Vital Farms, Inc. (VITL)32.2%$66.3M$33.7M$-134.3M-31.4% · 13F Jul 1
STOKE THERAPEUTICS INC (STOK)32.1%$-6.9M$45.6M$-186.8M-19.3% · 13F Jul 1
RAPPORT THERAPEUTICS INC (RAPP)31.9%$-111.5M$-87.5M$-187.5M-5.5% · Form 4 Nov 2
Oric Pharmaceuticals, Inc. (ORIC)31.7%$-129.5M$-111.0M$-148.0M-26.5% · 13F Jul 1
WhiteFiber, Inc. (WYFI)30.2%$-24.7M$45.7M$-267.3M-57.5% · 13D Aug 26
PTC THERAPEUTICS, INC. (PTCT)28.7%$682.6M$711.2M$-862.0M-26.0% · 13F Jul 1
Talen Energy Corp (TLN)28.2%$-219.0M$704.0M$-4.0B-1.7% · 13F Jul 1
Praxis Precision Medicines, Inc. (PRAX)27.4%$-303.3M$-249.1M$-311.1M-4.5% · 13F Jul 1
Olema Pharmaceuticals, Inc. (OLMA)26.2%$-162.5M$-146.7M$-155.8M-40.2% · 13F Jul 1
Palantir Technologies Inc. (PLTR)25.6%$1.6B$2.1B$-2.8B+24.5% · 13F Jul 1
Verastem, Inc. (VSTM)-25.3%$-209.5M$-137.5M$-9.6M+80.7% · 13F Jul 1
UroGen Pharma Ltd. (URGN)-26.2%$-153.5M$-162.4M$61.6M-21.3% · 13F Jul 1
Wise Group plc (WSE)-26.4%$498.7M$7.6B$1.7B-7.8% · 13F Jul 1
VERISIGN INC/CA (VRSN)-28.2%$825.7M$1.1B$109.1M+6.0% · Form 4 Sep 1
Zai Lab Ltd (ZLAB)-28.4%$-175.5M$-150.8M$307.9M+0.3% · Form 4 Nov 16
SYNAPTICS Inc (SYNA)-31.1%$-490.8M$149.4M$13.0M-7.4% · 13F Jul 1
Snowflake Inc. (SNOW)-31.4%$-1.3B$1.2B$312.2M+4.5% · 13F Jul 1
RingCentral, Inc. (RNG)-31.5%$43.4M$617.4M$-108.0M+75.7% · 13F Jul 1
SKYX Platforms Corp. (SKYX)-31.5%$-33.4M$-13.3M$-1.9M-53.7% · 13D Jul 14
TELEPHONE & DATA SYSTEMS INC /DE/ (TDS)-32.6%$-6.2M$589.9M$2.1B-18.4% · 13D Sep 3
SUTRO BIOPHARMA INC (STRO)-33.9%$-191.1M$-177.2M$45.0M-70.5% · 13F Jul 1
VERA THERAPEUTICS INC (VERA)-34.4%$-299.6M$-241.1M$194.3M-38.6% · 13F Jul 1
TYRA BIOSCIENCES INC (TYRA)-34.4%$-119.9M$-95.1M$72.5M-23.9% · 13D Sep 18
SUN COMMUNITIES INC (SUI)-34.9%$1.4B$864.2M$4.9B-3.2% · 13F Jul 1
PLUG POWER INC (PLUG)-36.9%$-1.6B$-535.8M$-139.0M-60.2% · 13F Jul 1
ThredUp Inc. (TDUP)-36.9%$-71.2M$-22.6M$43.7M+0.0% · Form 4 Nov 10
Relay Therapeutics, Inc. (RLAY)-37.6%$-276.5M$-235.5M$192.8M-7.3% · 13F Jul 1
QUANTUM CORP /DE/ (QMCO)-39.2%$-101.0M$-37.9M$-1.7M+31.3% · 13F Jul 1
SOLAREDGE TECHNOLOGIES, INC. (SEDG)-40.8%$-405.4M$104.3M$379.9M-61.2% · 13F Jul 1
StubHub Holdings, Inc. (STUB)-40.8%$-1.9B$192.6M$-34.4M-64.8% · 13F Jul 1
Ralliant Corp (RAL)-41.4%$-1.2B$397.6M$-37.7M-6.1% · 13F Jul 1
ROCKET PHARMACEUTICALS, INC. (RCKT)-41.4%$-223.1M$-190.0M$103.8M-40.1% · 13F Jul 1
Rallybio Corp (RLYB)-42.5%$-9.0M$-29.8M$47.3M-4.1% · 13F Jul 1
XENON PHARMACEUTICALS INC (XENE)-45.0%$-345.9M$-279.1M$218.0M+2.0% · Form 4 Oct 2
Resolute Holdings Management, Inc. (RHLD)-45.2%$-5.9M$196.1M$-51.4M+0.4% · Form 4 Aug 25
Velo3D, Inc. (VELO)-45.2%$-71.4M$-27.3M$-2.7M-79.7% · 13F Jul 1
Syndax Pharmaceuticals Inc (SNDX)-47.7%$-285.4M$-323.0M$290.0M-56.0% · 13F Jul 1
Rafael Holdings, Inc. (RFL)-48.8%$-30.5M$-18.9M$44.0M-75.8% · 13F Jul 1
Simulations Plus, Inc. (SLP)-65.5%$-64.7M$18.1M$3.6M+0.8% · 13F Jul 1
PRELUDE THERAPEUTICS INC (PRLD)-68.4%$-99.5M$-56.3M$53.5M-32.4% · 13F Jul 1
Scholar Rock Holding Corp (SRRK)-73.4%$-377.9M$-300.0M$218.7M+4.2% · Form 4 Oct 28
SUMMIT THERAPEUTICS INC (SMMT)-77.5%$-1.1B$-322.9M$-174.3M-25.8% · 13F Jul 1
REPLIMUNE GROUP INC (REPL)-103.6%$-313.9M$-280.3M$310.8M+29.2% · 13D Aug 12
PRECIGEN, INC. (PGEN)-103.7%$-250.6M$-87.8M$-1.5M-42.2% · Form 4 Aug 26
VOR BIOPHARMA INC (VOR)-108.7%$-696.0M$-142.7M$-48.8M-6.8% · 13D Jul 22

More in Red Flags: Earnings Manipulation Suspect (Beneish) · Distress Risk (Altman Z″) · Financial Restatement (8-K 4.02) · Auditor Change (8-K 4.01) · Late Filings (NT).

For education only — not investment advice. Past records do not guarantee future results. How each number is measured: Methodology.

Related

Earnings Manipulation Suspect (Beneish) · Track Record: how 13F signals scored · Practice timing

One email a week: the week’s new filings and research. Subscribe free

← Distress Risk (Altman Z″)  ·  Financial Restatement (8-K 4.02) →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.